Unicancer Center Georges Francois Leclerc Dijon

Molecular Imaging & Nuclear Medicine — IMATHERA Platform

Discipline
Nuclear Medicine / Molecular Imaging
Programme mentors
Prof. Bertrand Collin, Radiopharmacist
Duration
3-6 months
Type
Visiting Residency
Language requirements
French level B minimum

Programme description

Molecular imaging has become a crucial tool for cancer detection and management. Since 2011, the Nuclear Medicine Department of CGFL has been actively engaged in translational imaging research, hosting the IMATHERA platform, which offers a comprehensive approach to pharmaco-imaging and radiation therapy in a dedicated setting. The platform is ISO 9001 certified since 2024.

  • Translational research in pharmaco-imaging and radiation therapy
  • Preclinical imaging and radiobiology under a certified quality framework
  • Multidisciplinary collaborations across the full translational pipeline — radioimaging molecule design (ICMUB, CheMatech), preclinical validation (Oncodesign, IMATHERA), and patient image processing (CGFL, CHU Dijon)
  • Anchored within the GIE Pharm’image® ecosystem and close to INSERM, UB, CNRS research centres
Programme offered by:
Unicancer Center Georges Francois Leclerc Dijon

Person responsible for CTC programme:

Dr. Ilie Silvia Mihaela